Tyra Biosciences insider reports 4.8% stake

Tyra Biosciences reports a Schedule 13G/A showing beneficial ownership by Todd Harris.

Rhea-AI Filing Summary

Tyra Biosciences reports a Schedule 13G/A showing beneficial ownership by Todd Harris. As of March 31, 2026, the company reported 59,469,687 shares outstanding. The Reporting Person beneficially owns 2,913,342 shares, or 4.8% of the class, consisting of 1,358,631 shares held directly and 1,554,711 shares underlying options exercisable within 60 days.

The filing confirms sole voting and dispositive power over all 2,913,342 shares.

Insights

Corporate Governance Analyst

Majority of reported stake derives from exercisable options, not solely held shares.

The filing shows 2,913,342 shares beneficially owned as of March 31, 2026, representing 4.8% of 59,469,687 shares outstanding. Of that position, 1,554,711 shares are underlying options exercisable within 60 days, which is material to voting and disposal calculations.

Outcome depends on whether options are exercised; subsequent disclosures will show any change in float or voting if exercises occur.

Equity Markets Specialist

Holding size is below 5% reporting threshold but shows near‑term potential issuance from option exercise.

The reported 4.8% stake is under 5% and therefore routine for Schedule 13G/A treatment. The inclusion of 1,554,711 exercisable options means the economic and voting exposure could change if exercised within the 60‑day window referenced.

Market impact will depend on whether the options are exercised and whether any shares are sold; filings after exercise would disclose changes.

Key Figures

Shares outstanding: 59,469,687 shares Beneficial ownership: 2,913,342 shares Percent of class: 4.8% +2 more

5 metrics

Shares outstanding 59,469,687 shares as of March 31, 2026

Beneficial ownership 2,913,342 shares reported beneficial ownership by Todd Harris

Percent of class 4.8% percentage of common stock outstanding as of March 31, 2026

Directly held shares 1,358,631 shares shares held directly by the Reporting Person

Options exercisable 1,554,711 shares underlying stock options exercisable within 60 days of March 31, 2026

Key Terms

beneficial ownership, options exercisable within 60 days, sole dispositive power

3 terms

beneficial ownership regulatory

"The Reporting Person is the beneficial owner of 2,913,342 shares"

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

options exercisable within 60 days financial

"1,554,711 shares underlying stock options... exercisable within 60 days"

sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 2,913,342"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Todd Harris report in TYRA?

Todd Harris reports beneficial ownership of 2,913,342 shares, representing 4.8% of TYRA's common stock as of March 31, 2026. The position combines direct holdings and options exercisable within 60 days.

How many TYRA shares were outstanding as of the filing date?

The issuer reported 59,469,687 shares outstanding as of March 31, 2026. That figure is the basis for the 4.8% beneficial ownership calculation disclosed in the filing.

How is the 2,913,342‑share position composed?

The position comprises 1,358,631 shares held directly and 1,554,711 shares underlying stock options that are exercisable or may be exercised within 60 days of March 31, 2026.

Does Todd Harris have voting and dispositive power over these TYRA shares?

Yes. The filing states the Reporting Person has sole voting power and sole dispositive power over all 2,913,342 shares disclosed in the Schedule 13G/A.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/14/2026 - 04:56 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

Tyra Biosciences, Inc.

(Name of Issuer)

Common Stock, par value $0.0001 per share

(Title of Class of Securities)

90240B106

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 90240B106

1

Names of Reporting Persons

Todd Harris

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,913,342.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,913,342.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,913,342.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

4.8 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Tyra Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 2656 State Street, Carlsbad, CA 92008
Item 2.
(a)	Name of person filing: This statement is filed on behalf of Todd Harris (the "Reporting Person").
(b)	Address or principal business office or, if none, residence: The principal business address of the Reporting Person is c/o Tyra Biosciences, Inc., 2656 State Street, Carlsbad, CA 92008.
(c)	Citizenship: The Reporting Person is a citizen of the United States.
(d)	Title of class of securities: Common Stock, par value $0.0001 per share
(e)	CUSIP No.: 90240B106
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: The ownership information presented herein represents beneficial ownership of Common Stock of the Issuer as of March 31, 2026, based upon 59,469,687 shares of Common Stock outstanding as of March 31, 2026, as provided by the Issuer. The Reporting Person is the beneficial owner of 2,913,342 shares of Common Stock, which consist of (i) 1,358,631 shares of Common Stock held directly by the Reporting Person and (ii) 1,554,711 shares of Common Stock underlying stock options held directly by the Reporting Person that are currently exercisable or may be exercised within 60 days of March 31, 2026.
(b)	Percent of class: 4.8%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,913,342
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,913,342
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Ownership of 5 percent or less of a class
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.	Certifications:
	Not Applicable

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Todd Harris

Signature:	/s/ Todd Harris
Name/Title:	Todd Harris
Date:	05/14/2026